ANTIBIOTICE
84 articole · RSS
Antibiotice Eyes 6% Higher Profit In 2013
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) estimates its net profit will rise 6% to 29 million lei (EUR6.5 million) in 2013, according to the company’s revenue and expenditure bu...
Antibiotice's Net Profit Rises 33% To RON27.4M In 2012
Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Wednesday said its preliminary net profit rose 33% in 2012 to 27.4 million lei (EUR6.1 million).
Drugmaker Antibiotice Sees 17% Higher Exports In 2013, After FDA Audit
Romanian state-run drug producer Antibiotice Iasi (ATB.RO) forecasts 17% higher exports in 2013 from $20 million in 2012, fueled by expanded partnerships on the US market as well as on other...
Antibiotice CEO: We Plan To Reach Sales Of EUR124M By 2016
Romanian state-run drug producer Antibiotice Iasi (ATB.RO) is aiming for EUR124 million sales by 2016, an increase of 77% from the almost EUR70 million expected this year.
What Is Drugmaker Antibiotice’s Success Strategy
Romanian state-owned drug producer Antibiotice Iasi (ATB.RO) will hit its sales and profit targets this year, says general manager Ioan Nani, while 2013’s sales should follow the trend of th...
Antibiotice January-September Net Profit Rises To RON26.6M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Thursday said its net profit rose 7% to 26.6 million lei (EUR6 million) in the first nine months, fueled by a similar increase in sales...
Romania Mulls Increasing Sales Agents Number At Drugmaker Antibiotice To Boost Operations
The Romanian Government Wednesday authorized the purchasing of 27 vehicles for Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO), which is aimed to increase the number of sales age...
Antibiotice 1H Net Profit Rises 11% To RON25.7M
Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Thursday said its net profit rose 11.2% on the year to 25.75 million lei (EUR5.8 million) in the first half, helped by higher sale...
Antibiotice 1Q Net Profit Inches Down 2.2% To RON13M
Romanian drugmaker Antibiotice Iasi (ATB.RO) Tuesday reported a net profit of 12.97 million lei (EUR2.9 million) for the first quarter, down 2.2% on the year, as higher financial costs hurt...